GENE ONLINE|News &
Opinion
Blog

Region
China’s Simcere Gains Regional Rights for Two Alzheimer’s Drugs
2021-07-01
SK Bioscience Submits Phase 3 IND for First Korea-Made COVID-19 Vaccine
2021-06-29
Korea to Begin Production of Sputnik Light COVID-19 Vaccine in September
2021-06-29
Gilead’s Yescarta Becomes First CAR-T Therapy to Score Regulatory Approval in China
2021-06-27
China’s Legend Biotech to Build a CAR-T Therapy Production Site in Belgium
2021-06-24
China’s Qitan Technology Raises Over RMB400 Million in Series B Funding to Develop Nanopore Gene Sequencing
2021-06-23
Alibaba Health, Berry Oncology Expand Scale of Early Cancer Detection in China
2021-06-23
Chinese Oncology Drugmaker to Raise over 600 Million in Hong Kong IPO
2021-06-22
BMS Initiates Global Partnership to Advance Eisai’s First ADC to Market
2021-06-20
From Great Challenges to Great Opportunities: An Outlook on US-China Biotech Relationships
2021-06-18
South Korea Seeks Global Partners for Upping COVID-19 Vaccine Production
2021-06-18
Singapore and Australia’s Prime Ministers Discuss Initiation of Air Travel Bubble
2021-06-13
Japanese Biotech Raises $37 Million in Series C to Develop Stem Cell Therapy for Heart Failure
2021-06-13
As BIO 2021 Approaches, Taiwan’s DCB Reveals Competitive Bio-Innovations to Watch Out For
2021-06-11
Korea’s Incheon Airport to Open a Cool Cargo Center to Store COVID-19 Vaccines
2021-06-10
1 20 21 22 23 24 42
LATEST
Biotech in Beauty: Engineered Skin Bacteria Designed To Treat Acne
2024-05-10
Revolutionizing Treatment: ASGCT’s Clinical Trials Spotlight on Immunotherapy, Cancer Vaccines, and Auditory Diseases
2024-05-09
Advancing Health: ASGCT’s Clinical Trials Spotlight on Cell Therapy and Cell-Based Gene Therapy
2024-05-09
Infinitopes’ Article in Peer-Reviewed Journal Seeks to Unlock the Potential of Cancer Vaccines
2024-05-09
Profluent Achieves Human Genome Editing Milestone Using OpenCRISPR-1: The First AI-Generated, Open-Source Gene Editor
2024-05-08
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
EVENT
Scroll to Top